Viewing StudyNCT04471428

Home Icon Home Search Icon Search Alerts Icon Stocks Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs eRecord Icon eRecord
Main Search All Studies All Organizations Report Bug
View Study With Definitions
Ignite Creation Date: 2024-05-06 @ 2:57 PM
Last Modification Date: 2024-10-26 @ 1:40 PM
Study NCT ID: NCT04471428
Status: ACTIVE_NOT_RECRUITING
Last Update Posted: 2024-05-30
First Post: 2020-07-07
Brief Title: Study of Atezolizumab in Combination With Cabozantinib Versus Docetaxel in Patients With Metastatic Non-Small Cell Lung Cancer Previously Treated With an Anti-PD-L1PD-1 Antibody and Platinum-Containing Chemotherapy
Sponsor: Hoffmann-La Roche
Organization: Hoffmann-La Roche
Overview Dates Organization Conditions Design Enrollment Locations Outcomes

Conditions & Keywords Data

Conditions:
Name
Carcinoma Non-Small-Cell Lung
Keywords: